Literature

Protocols

• TECHNOTHROMBIN^® TGA Mouse Protocol

Literature

• Leyla Ay et al.
  Thrombin generation in morbid obesity: significant reduction after weight loss
  2009 Journal of Thrombosis and Haemostasis doi: 10.1111/j.1538-7836.2010.03766.x

• Lopez-Vilchez I. et al.
  Serotonin enhances platelet procoagulant properties and their activation induced during platelet tissue factor uptake
  Cardiovascular Research, doi:10.1093/cvr/cvp205

• Haubold K. et al.
  Tissue factor procoagulant acitivty of plasma micropaticles is increased in patients with early-stage prostate cancer
  Schattauer 2009, doi: 10.1160/TH08-10-0654

• Buyue et al.
  Fucosylated chondroitin sulfate inhibits plasma thrombin generation via targeting of the factor IXa heparin-binding exosite
  Blood 2009, doi:10.1182/blood-2009-02-203661

• Buyue et al.
  Thrombin generation and venous thrombosis. The heparin-binding exosite of factor IXa is a critical regulator of plasma

  Blood 2008, doi:10.1182/blood-2008-01-136820

• Weeterings C. et al.
  The glycoprotein Ib-IX-V complex contributes to tissue factor independent thrombin generation by recombinant factor VIIa on the activated platelet surface
  Blood 2008; 112: 3227-3233

• Buyue Y. et al.
  The heparing-binding exosite of factor IXa is a critical regulator of plasma thrombin generation and venous thrombosis
  Blood 2008; 112: 3234-3241
  

• Lechner D. et al.
  Comparison between didiopathic deep vein thrombosis of the upper and lower extremity regarding risk factors and recurrence
  JTH 2008; 6: 1269-1274

• Weeterings C. et al.
  The glycoprotein lb-IX-V complex contributes to tissue factor-indipendent thrombin generation by recombinant factor VIIa on the activated platelet surface
  Blood 2008; doi: 10.1182/blood-2008-02-139113

• Hamd R. et al.
  Increased thrombin generation in women with a history of preeclampsia
  Thromb. Res. 2008; doi: 10.1016/j. thromres. 2008.03.022

• Lechner D. et al.
  Chemotherapy-induced thrombin generation via procoagulant endothelial microparticles is independent of tissue factor activity
  Journal of Thrombosis and Haemostasis 2007, 5: 2445?2452

   

• Orbe J. et al.
  Increased thrombin generation after acute versus chronic coronary desease as assessed by the thrombin generation test
  Thromb. Haemost. 2008; 382-387

• Lechner D. et al.
  Chemotherapy-induced thrombin generation via procoagulant endothelial micrparticles is independent of tissue factor activity
  JTH, 2007; 5:2445-2452

• Leryer A. et al.
  Cellular Origins and Thrombogenic Activity of Microparticels Isolated from Human Atherosclerotic Plaques
  Journal of the American College of Cardiology, 2007, Vol. 49, No. 7; 772-777

• Suman G. et al.
  Blood coagulation activation and fibrinolysis during a downhill marathon run 
  Blood Coagulation and Fibrinolysis (2007), 18, 435-440  

• Siegemund A. et al.
  Thrombin Generation in Children with Hemophilia and VWD ? Comparing a Fluorimetric Method and ROTEM
  2006, 37th Hemophilia Symposium Hamburg

    

• Hron G. et al. 
  

  Identification of Patients at Low Risk for Recurrent Venous Thromboembolism by Measuring Throbin Generation

  JAMA 2006, July 26, 2006 - Vol 296, No. 4, 397-402  

• Váradi K. et al. 
  Thrombin generation assay and other universal test for monitoring haemphilia therapy
  Haemophilia 2004, 10, (Suppl. 2), 17-21  

Orals

• K. Váradi, P. Turecek 
  Thrombin Generation for Hemophilie Treatment Monitorin
  Pekelharing Symposium, Leipzig 2007

• Wiens L. 
  Influence of pre-analytic variables on thrombin generation
  GTH Dresden 2007

• Male C. et al. 
  Thrombin Generation Assay for Monitoring FVIII Inhibitor Bypassing Agent
  GTH Dresden 2007, FV26

• Kyrle P. et al. 
  Thrombosis generation and venous thrombosis
  52nd Annual Scientific and Standardization Committee Meeting, Oslo 2006

• Kyrle P. et al. 
  Identification of patients with a low risk of recurrent venous thromboembolism by measuring thrombin generation. 
  GTH Basel 2006, V65

• Isobe H. et al. 
  Apoptotic microparticles derived from endothelial cells, smooth muscle cells and monocytes induce thrombin generation via different coagulation pathways.
  GTH Basel 2006, V113

Posters

• B. Myers et al.
  Preliminary results of baseline thrombin generation and firbrinolysis in women with previous pregnancy-associated venous thrombosis: thrombin generation appears increased and fibrinolytic activity reduced compared to healthy femal controls
  ISTH 2009

• Riddell et al.
  Comparison of Three different Thrombin Generation Assays in Patients with Haemophilia
  ISTH 2009

• Vlieg et al.
  Thrombophilia, hypercoagulability, and environment, and the risk of venous thrombo-embolism (THE-VTE study)
  ISTH 2009

• Speer O. et al.
  Apoptosis in platelets from pediatric patients with acute immune thrombocytopenia purpura is ameliorated by IVIg
  ASH 2008

• Ryland JK. et al.
  A comporative assesment of two Thrombin generation assays in the analysis of samples from post-thrombotic patients
  BSHT 2008

• Berntop E. et al.
  Thrombin generation assay for optimizing hamophilia A therapy in patients with inhibitor
  WFH 2008, Istanbul

• Eichinger S. et al.
  Effects of Recombinant Factor VIIa (NovoSeven^®) on Restoring Thrombin Generation in Patients with Hemophilia A and Antibodies to Factor VIII
  WFH 2008, Istanbul

• Haushofer A. et al.
  Comparison of three commercial thrombin genration assays in different patients settings
  GTH 2008

• Kaufmann V. et al.
  Role of Microparticels in Thrombin Genration in Patients at Risk of Atherothrombosis
  ASH 2007

• Wiens L. et al.
  Thrombin Generation in mammal
  OEGKL DGKL 2007

• Siegemund T. et al. 
  Inhibitor against F V - Monitoring with thrombin generation
  ISTH Geneva 2007

• Siegemund T. et al. 
  Monitoring NovoSeven therapie with Different Methods
  ISTH Geneva 2007

• Eichinger S. et al. 
  Effects of Recombinant Factor VIIa (NovoSeven^®) on Restoring Thrombin Generation in Patients with Hemophilia A and Antibodies to Factor VIII
  ISTH Geneva 2007

• Pock K. et al. 
  Thrombin generation capacity is impaired in methylene-blue (MB) treated plasma units compard to single-donor FFP, a pharmaceutically licensed cogulation active and solvent-detergent (S/D) treated plasma product and a universally applicable S/D plasma under development
  ISTH Geneva 2007

• Kaufmann V. et al. 
  Measurement of thrombin generation in patients at risk atherothormbosis
  ISTH Geneva 2007

• Kaufmann V. et al. 
  Micropartikels in Thrombin Generation - A Significant Parameter Influencing Peak Thrombin Levels
  ISTH Geneva 2007

• Lösche W. et al. 
  Thrombin generation in on-pump cardiac surgery patients
  GTH Dresden 2007

• Kaufmann V .et al. 
  Mikroparticles are a major determinant for thrombin generation measured by TECHNOTHROMBIN^® TGA
  ASH Orlando 2006

• Wiens L. et al. 
  Influence of pre-analytic variables on thrombin generation
  DGKL Mannheim 2006

• Wiens L. et al. 
  Thrombin generation during pregnancy and postpartum
  DGKL Mannheim 2006

• Kaufmann V. et al. 
  TECHNOTHROMBIN^® TGA a novel Thrombin Generation Assay suitable for the new routine coagulation analyzer Ceveron^® alpha  
  WFH, Vancouver 2006

• H. Isobe et al.
  Evaluation of TECHNOTHROMBIN^® TGA in patients with venous or arterial thrombotic tendencies: Circulating micro particles as possible causative factors.
  International Congress on Thromobis, Tel Aviv 2006

• Wiens L. et al.
  Thrombin Generation: First Experiences Using Two Different Assays: Endogeneous Thrombin Potential (ETP, Dade Behring) and TECHNOTHROMBIN^® TGA (Technoclone)
  GTH Basel 2006, P140

• Kaufmann V. et al.
  Validation of the thrombin generation assay TECHNOTHROMBIN^® TGA
  GTH Basel 2006, P286

• Isobe H. et al. 
  Apoptotic microparticles derived from endothelial cells, smooth muscle cells and monocytes induce thrombin generation via different pathways.
  ASH Atlanta 2005, P148

• Váradi K. et al. 
  Applications of Thrombin Generation Assay in Characterizing FVIII Inhibitor Bypassing Agents
  ISTH Sydney 2005